Related Experiment Video
Updated: Jul 16, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Glaucoma as a neurodegenerative disease.
1Departments of Ophthalmology, St Michael's Hospital, University of Toronto, Canada. guptan@smh.toronto.on.ca
Current Opinion in Ophthalmology
|February 16, 2007
Summary
Glaucoma, a leading cause of vision loss, involves retinal ganglion cell death. Viewing glaucoma as a neurodegenerative disease may reveal new treatments beyond lowering eye pressure.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Glaucoma causes irreversible vision loss through retinal ganglion cell death.
- Elevated intraocular pressure is a risk factor, but vision loss persists despite treatment.
- Similarities between glaucoma and neurodegenerative diseases suggest non-pressure-dependent mechanisms.
Purpose of the Study:
- To explore the hypothesis of glaucoma as a neurodegenerative disease.
- To identify mechanisms of neural injury in glaucoma independent of intraocular pressure.
- To stimulate novel therapeutic strategies for vision preservation.
Main Methods:
- Comparative analysis of glaucoma and neurodegenerative disease pathologies.
- Review of existing literature on retinal ganglion cell death and central visual system involvement.
- Examination of cellular injury and death mechanisms.
Main Results:
- Glaucomatous injury affects brain structures like the lateral geniculate nucleus and visual cortex.
- Central visual system damage involves oxidative injury and glutamate toxicity.
- These mechanisms are also implicated in other neurodegenerative conditions.
Conclusions:
- Glaucoma can be effectively conceptualized as a neurodegenerative disease.
- This perspective may drive the development of novel, pressure-independent treatments.
- Understanding these pathways could prevent further vision loss in glaucoma patients.
More Related Videos
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...